A41D (p.Ala41Asp) variant of LOX (Protein-lysine 6-oxidase)
A41D (p.Ala41Asp) in LOX (Protein-lysine 6-oxidase) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.31 / 1. The record also includes population frequency data and structural context.
A41D (p.Ala41Asp) variant details
- p.Ala41Asp
- NCI-TCGA TCGA novel
- TOPMed rs984576522
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.311
- REVEL 0.10
- CADD 22.80
- PolyPhen-2 0.16
- SIFT 0.08
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available